DrugId:  1
1. Name:  Sermorelin
2. Groups:  Approved, Withdrawn
3. Description:  Sermorelin acetate is the acetate salt of an amidated synthetic 29-amino acid peptide (GRF 1-29 NH 2 ) that corresponds to the amino-terminal segment of the naturally occurring human growth hormone-releasing hormone (GHRH or GRF) consisting of 44 amino acid residues
4. Indication:  For the treatment of dwarfism, prevention of HIV-induced weight loss
DrugId:  2
1. Name:  Somatotropin
2. Groups:  Approved, Investigational
3. Description:  Recombinant human growth hormone (somatotropin) 191 residues, MW 22.1 kD, synthesized in E. coli
4. Indication:  For treatment of dwarfism, acromegaly and prevention of HIV-induced weight loss
